FI102756B1 - Menetelmä terapeuttisesti käyttökelpoisten 6H-bentsfuro[3a,3,3-ef][2]bentsatsepiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten 6H-bentsfuro[3a,3,3-ef][2]bentsatsepiinijohdannaisten valmistamiseksiInfo
- Publication number
- FI102756B1 FI102756B1 FI895213A FI895213A FI102756B1 FI 102756 B1 FI102756 B1 FI 102756B1 FI 895213 A FI895213 A FI 895213A FI 895213 A FI895213 A FI 895213A FI 102756 B1 FI102756 B1 FI 102756B1
- Authority
- FI
- Finland
- Prior art keywords
- benzofuro
- benzazepine derivatives
- therapeutically utilizable
- preparing therapeutically
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Compression Or Coding Systems Of Tv Signals (AREA)
- Eye Examination Apparatus (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Processing Of Meat And Fish (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4652287A | 1987-05-04 | 1987-05-04 | |
US4652287 | 1987-05-04 | ||
PCT/US1988/001542 WO1988008708A1 (en) | 1987-05-04 | 1988-05-04 | Compounds for the treatment of alzheimer's disease |
US8801542 | 1988-05-04 | ||
CA000569641A CA1338326C (en) | 1987-05-04 | 1988-06-16 | Compounds for the treatment of alzheimer's disease |
CA569641 | 1988-06-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI895213A0 FI895213A0 (fi) | 1989-11-02 |
FI102756B FI102756B (fi) | 1999-02-15 |
FI102756B1 true FI102756B1 (fi) | 1999-02-15 |
Family
ID=42046403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI895213A FI102756B1 (fi) | 1987-05-04 | 1989-11-02 | Menetelmä terapeuttisesti käyttökelpoisten 6H-bentsfuro[3a,3,3-ef][2]bentsatsepiinijohdannaisten valmistamiseksi |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0363415B1 (fi) |
JP (1) | JP2755403B2 (fi) |
KR (1) | KR100195399B1 (fi) |
AT (1) | ATE411026T1 (fi) |
AU (1) | AU632458B2 (fi) |
CA (1) | CA1338326C (fi) |
DE (1) | DE3856594D1 (fi) |
DK (1) | DK175839B1 (fi) |
FI (1) | FI102756B1 (fi) |
WO (1) | WO1988008708A1 (fi) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
CA2108880A1 (en) * | 1991-05-14 | 1992-11-15 | Ernir Snorrason | Treatment of fatigue syndrome with cholinesterase inhibitors |
US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
US6316439B1 (en) * | 1993-10-15 | 2001-11-13 | Aventis Pharamaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6323195B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6323196B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6407229B1 (en) | 1994-10-21 | 2002-06-18 | Sanochemia Pharmazeutika Ag | Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2] benzazapine |
AT401058B (de) * | 1994-10-21 | 1996-06-25 | Waldheim Pharmazeutika Gmbh | Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins |
NZ294191A (en) * | 1994-10-21 | 1998-10-28 | Waldheim Pharmazeutika Gmbh | Process for preparing 4a,5,9,10,11,12-hexahydro-6h-benzofuro[3a,3,2-ef][2]benzazepine derivatives and intermediates thereof |
GB9506843D0 (en) | 1995-04-03 | 1995-05-24 | Chiroscience Ltd | Oxidative process and products thereof |
GB9514821D0 (en) * | 1995-07-19 | 1995-09-20 | Sod Conseils Rech Applic | Galanthamine derivatives |
GB9519267D0 (en) * | 1995-09-21 | 1995-11-22 | Chiroscience Ltd | Preparation of alkaloids |
AT403803B (de) * | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
AU1738800A (en) | 1998-11-23 | 2000-06-13 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
AU2004242546B2 (en) * | 1998-11-23 | 2008-05-15 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
HUP0104778A3 (en) | 1998-12-24 | 2004-05-28 | Janssen Pharmaceutica Nv | Controlled release galantamine composition |
MXPA02005667A (es) | 1999-12-10 | 2004-09-10 | Bonnie Davis | Analogos de galantamina y licoramina como moduladores de los receptores nicotinicos. |
CA2368966A1 (en) | 2000-03-31 | 2001-10-11 | Sanochemia Pharmazeutika Aktiengesellschaft | New derivatives and analogues of galanthamine |
US20030162770A1 (en) | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
EP1777222A1 (en) * | 2005-09-22 | 2007-04-25 | Galantos Pharma GmbH | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
ATE473219T1 (de) * | 2005-09-22 | 2010-07-15 | Galantos Pharma Gmbh | Cholinerge enhancer mit verbesserter durchgängigkeit durch die blut-hirn-schranke zur behandlung von krankheiten, die mit kognitiven störungen einhergehen |
US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
JP5504253B2 (ja) | 2008-04-14 | 2014-05-28 | ニューロダイン ライフ サイエンス インコーポレイテッド | ヒトの脳疾患の治療のためのプロドラッグとしてのガランタミン誘導体 |
UY32147A (es) | 2008-09-29 | 2010-04-30 | Abbott Lab | Derivados de indol y de indolina y métodos para usarlos |
US9625475B2 (en) | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
EA037187B1 (ru) | 2010-02-09 | 2021-02-17 | Дзе Джонс Хопкинс Юниверсити | Способ и композиция для лечения когнитивного расстройства |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
MX362886B (es) | 2012-12-13 | 2019-02-22 | H Lundbeck As | Composición sinérgica que comprende vortioxetina y donepezilo para incrementar los niveles de acetilcolina en el cerebro, y el uso de la misma en el tratamiento de una disfunción cognitiva. |
WO2014144801A1 (en) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Methods and compositions for improving cognitive function |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3673177A (en) * | 1970-05-04 | 1972-06-27 | American Cyanamid Co | Substituted 4-(anilinomethylene)-3-galanthamaninones |
PL122665B1 (en) * | 1978-11-21 | 1982-08-31 | Edinen Zentar Chim | Process for preparing novel dienones of narvedine type and their derivatives |
US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
NL8800350A (nl) * | 1988-02-12 | 1989-09-01 | Stichting Biomedical Research | Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen. |
-
1988
- 1988-05-04 KR KR1019880701794A patent/KR100195399B1/ko active IP Right Review Request
- 1988-05-04 AU AU18084/88A patent/AU632458B2/en not_active Expired
- 1988-05-04 EP EP88905083A patent/EP0363415B1/en not_active Expired - Lifetime
- 1988-05-04 JP JP63504783A patent/JP2755403B2/ja not_active Expired - Fee Related
- 1988-05-04 WO PCT/US1988/001542 patent/WO1988008708A1/en active IP Right Grant
- 1988-05-04 DE DE3856594T patent/DE3856594D1/de not_active Expired - Lifetime
- 1988-05-04 AT AT88905083T patent/ATE411026T1/de not_active IP Right Cessation
- 1988-06-16 CA CA000569641A patent/CA1338326C/en not_active Expired - Lifetime
-
1989
- 1989-11-02 FI FI895213A patent/FI102756B1/fi not_active IP Right Cessation
- 1989-11-03 DK DK198905491A patent/DK175839B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE411026T1 (de) | 2008-10-15 |
KR890701107A (ko) | 1989-12-19 |
JP2755403B2 (ja) | 1998-05-20 |
DK549189D0 (da) | 1989-11-03 |
FI895213A0 (fi) | 1989-11-02 |
AU1808488A (en) | 1988-12-06 |
KR100195399B1 (ko) | 1999-06-15 |
JPH02503794A (ja) | 1990-11-08 |
CA1338326C (en) | 1996-05-14 |
EP0363415A4 (en) | 1993-03-17 |
DK549189A (da) | 1990-01-03 |
EP0363415B1 (en) | 2008-10-15 |
AU632458B2 (en) | 1993-01-07 |
FI102756B (fi) | 1999-02-15 |
DE3856594D1 (de) | 2008-11-27 |
EP0363415A1 (en) | 1990-04-18 |
DK175839B1 (da) | 2005-03-21 |
WO1988008708A1 (en) | 1988-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI102756B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 6H-bentsfuro[3a,3,3-ef][2]bentsatsepiinijohdannaisten valmistamiseksi | |
GR3004925T3 (fi) | ||
FI93117C (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi | |
GR3005470T3 (fi) | ||
HUT68166A (en) | Process for preparing substituted piperidines | |
ZA863382B (en) | Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs | |
HU901428D0 (en) | Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives | |
HUT47430A (en) | Process for producing pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for treating alcoholizmus | |
HU908436D0 (en) | Process for the production of 10-(2'-hydroxy-3"-polyoxaalkyl/1,4,7-tris-carboxymethyl-1,4,7,10-tetraazacyclododecanes | |
HU908437D0 (en) | Process for the production of 10-(2'-hydroxy-3'-alcoxy-1,4,7-tris-carboxymethyl-1,4,7,10-tetraazacyclododecanes | |
GR3001310T3 (en) | Hydroxypyrazole derivatives, process for their preparation and their use against microbes | |
EP0297496A3 (en) | Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives | |
DE3463143D1 (en) | 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same | |
PT86623A (pt) | Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles | |
GR3002884T3 (en) | Substituted chinoxalyl-imidazolidine-2,4-diones, process for their preparation, their use as medicaments and pharmacological preparations | |
ZA88639B (en) | Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned | |
GB2210040B (en) | The new process for the preparation of 3-(4'-bromobiphenyl-4-yl) tetralin-1-one | |
ZA903944B (en) | Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them | |
EP0365913A3 (en) | Substituted 2-aminothiazoles | |
HU905030D0 (en) | Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds | |
HUT46321A (en) | Process for producing pyrethrinoid derivatives | |
FI92393B (fi) | Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi | |
DE3469358D1 (en) | Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments | |
YU116389A (en) | Process for preparing derivatives of 1,3-diazolyl-2-propanole | |
YU39287A (en) | Process for preparation of derivatives 1,3 diazolyle-2-propanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Owner name: DAVIS, BONNIE |
|
MA | Patent expired |